Inventor · disambiguated record
Zhao Dang
Also filed as: Dang zhao
5 granted patents·4 pending applications·15 citations·filing 2019–2024
78Inventor score
Files withBIOCRYST PHARM INC9
Top patents by PatentIndex Score
9 records- 0195US11708347B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jul 25, 2023·3 cites·9 claims
- 0295US11370774B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2021·Granted Jun 28, 2022·4 cites·3 claims
- 0394US11866418B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2022·Granted Jan 9, 2024·2 cites·17 claims
- 0493US11021458B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2019·Granted Jun 1, 2021·5 cites·12 claims
- 0591US12043610B2Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2022·Granted Jul 23, 2024·1 cites·9 claims
- 0686US2024294494A1Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitorsBIOCRYST PHARM INC·Filed 2024·Application pending·0 cites
- 0757US2024239752A1Bicyclic heteroaromatic inhibitors of klk5BIOCRYST PHARM INC·Filed 2022·Application pending·0 cites
- 0853US2023159536A1Pyrrolopyrimidine amines as complement inhibitorsBIOCRYST PHARM INC·Filed 2021·Application pending·0 cites
- 0951US2025275991A1Oral complement factor d inhibitorsBIOCRYST PHARM INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhao Dang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →